Arthur F. Ryan, Director at REGENERON PHARMACEUTICALS, INC. (REGN), sold 100 shares at $713.82 ($72K) on 2023-07-03, disclosed to the SEC on 2023-07-06.
Scheduled sale ($72k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $710.09 | 1 | $710 | 1.0% |
| 2 | $711.95 | 1 | $712 | 1.0% |
| 3 | $713.82 | 6 | $4K | 6.0% |
| 4 | $714.65 | 10 | $7K | 10.0% |
| 5 | $715.23 | 7 | $5K | 7.0% |
| 6 | $716.74 | 29 |
| $21K |
| 29.0% |
| 7 | $717.57 | 22 | $16K | 22.0% |
| 8 | $718.71 | 12 | $9K | 12.0% |
| 9 | $719.36 | 11 | $8K | 11.0% |
| 10 | $720.15 | 1 | $720 | 1.0% |
| Total | $716.88 avg | 100 | $72K | 100% |
| Filing → |
| REGN | SELL | 2026-04-03 | $78K | — | Filing → |
| REGN | SELL | 2026-03-03 | $79K | — | Filing → |
| REGN | SELL | 2026-02-11 | $78K | — | Filing → |